Gene · 4967
Papers1,711
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,711
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia. | Cancer Res | 2024 | 38266099 | PubTator, text mining | PubMed |
| Acetyl-CoA production by Mediator-bound 2-ketoacid dehydrogenases boosts de novo histone acetylation and is regulated by nitric oxide. | Mol Cell | 2024 | 38242130 | PubTator, text mining | PubMed |
| Metabolic Bypass Rescues Aberrant S-nitrosylation-Induced TCA Cycle Inhibition and Synapse Loss in Alzheimer's Disease Human Neurons. | Adv Sci (Weinh) | 2024 | 38235614 | PubTator, text mining | PubMed |
| Use of Machine Learning for the Identification and Validation of Immunogenic Cell Death Biomarkers and Immunophenotypes in Coronary Artery Disease. | J Inflamm Res | 2024 | 38229693 | PubTator, text mining | PubMed |
| Roles of ubiquitin‑specific protease 13 in normal physiology and tumors (Review). | Oncol Lett | 2024 | 38192665 | PubTator, text mining | PubMed |
| Comprehensive analysis of a tryptophan metabolism-related model in the prognostic prediction and immune status for clear cell renal carcinoma. | Eur J Med Res | 2024 | 38183155 | PubTator, text mining | PubMed |
| Glutamine addiction in tumor cell: oncogene regulation and clinical treatment. | Cell Commun Signal | 2024 | 38172980 | PubTator, text mining | PubMed |
| p32 regulates glycometabolism and TCA cycle to inhibit ccRCC progression via copper-induced DLAT lipoylation oligomerization. | Int J Biol Sci | 2024 | 38169635 | PubTator, text mining | PubMed |
| WNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic Cancers. | Cancer Res Commun | 2024 | 38112643 | PubTator, text mining | PubMed |
| Role of DDX1 in the oxidative response of ataxia telangiectasia patient-derived fibroblasts. | Redox Biol | 2024 | 38096740 | PubTator, text mining | PubMed |
| ARL6IP1 gene delivery reduces neuroinflammation and neurodegenerative pathology in hereditary spastic paraplegia model. | J Exp Med | 2024 | 37934410 | PubTator, text mining | PubMed |
| Glucose Deprivation Promotes Pseudohypoxia and Dedifferentiation in Lung Adenocarcinoma. | Cancer Res | 2024 | 37934116 | PubTator, text mining | PubMed |
| The concentration of glucose in the media influences the susceptibility of stallion spermatozoa to ferroptosis. | Reproduction | 2024 | 37870246 | PubTator, text mining | PubMed |
| Succinylation modification: a potential therapeutic target in stroke. | Neural Regen Res | 2024 | 37843212 | PubTator, text mining | PubMed |
| Gut microbial GABAergic signaling improves stress-associated innate immunity to respiratory viral infection. | J Adv Res | 2024 | 37353002 | PubTator, text mining | PubMed |
| Post-translational modulation of cell signalling through protein succinylation. | Explor Target Antitumor Ther | 2023 | 38213532 | PubTator, text mining | PubMed |
| Circular RNAs: Promising Treatment Targets and Biomarkers of Ischemic Stroke. | Int J Mol Sci | 2023 | 38203348 | PubTator, text mining | PubMed |
| Whole genome sequencing reveals population diversity and variation in HIV-1 specific host genes. | Front Genet | 2023 | 38179408 | PubTator, text mining | PubMed |
| Neither too much nor too little: mitochondrial calcium concentration as a balance between physiological and pathological conditions. | Front Mol Biosci | 2023 | 38148906 | PubTator, text mining | PubMed |
| Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma. | Int J Mol Sci | 2023 | 38139462 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4967/papers?page=6